Market Place
Sourcing Support
Twist Bio Expands Antibody Discovery With Bispecific License Deal
17 Feb 2026 //
BUSINESSWIRE
Twist Bio Unveils Advanced Library Prep Kits With Unique Enzymes
10 Feb 2026 //
BUSINESSWIRE
Twist Bio Announces Inducement Grants Under NASDAQ LR 5635(C)(4)
03 Feb 2026 //
BUSINESSWIRE
Twist Bio Reveals Q1 2026 Financials
02 Feb 2026 //
BUSINESSWIRE
Twist Bio Reveals Q1 Fiscal 2026 Revenue Update
12 Jan 2026 //
BUSINESSWIRE
Twist Bio To Present At J.P. Morgan 2026 Health Conference
18 Dec 2025 //
BUSINESSWIRE
Twist Bio Launches Plasmid Preps For Nucleic Acid Therapy
04 Dec 2025 //
BUSINESSWIRE
Twist Bio To Present At Wolfe Research Healthcare Conference
04 Nov 2025 //
BUSINESSWIRE
Twist Bio Announces Inducement Grants Under NASDAQ LR 5635(C)(4)
03 Nov 2025 //
BUSINESSWIRE
Twist Bio To Report Fy2025 Q4 And Full-Year Financials On Nov
23 Oct 2025 //
BUSINESSWIRE
Twist Bioscience, Element Biosciences Launch Trinity Freestyle
06 Oct 2025 //
BUSINESSWIRE
Twist Bio Publishes Study on Biosecurity in AI Protein Design
02 Oct 2025 //
BUSINESSWIRE
Twist Bio to Present at Baird 2025 Global Healthcare Conference
03 Sep 2025 //
BUSINESSWIRE
Twist Bioscience Launches Oncology CGP Panel For Precision Med
19 Aug 2025 //
BUSINESSWIRE
Twist Bioscience Adds Trynka Shineman Blake to Director Board
06 Aug 2025 //
BUSINESSWIRE
Twist Bioscience Launches Humanized Transgenic Mouse Model
31 Jul 2025 //
BUSINESSWIRE
Twist Bioscience Offers Express Delivery for All Gene Fragments
07 Jul 2025 //
BUSINESSWIRE
Twist, Element Partner to Evolve NGS with End-to-End Tools
22 May 2025 //
BUSINESSWIRE
Twist Bioscience and Ginkgo Bioworks Revise Collaboration
08 May 2025 //
BUSINESSWIRE
Twist Bioscience Spins Out DNA Data Storage as Independent Company
05 May 2025 //
BUSINESSWIRE
Twist Bioscience Reports Fiscal 2025 Q2 Results
05 May 2025 //
BUSINESSWIRE
Twist Bioscience Launches High Throughput UDI Adapter System
24 Apr 2025 //
BUSINESSWIRE
Twist Bioscience Offers Clonal Genes to Global Researchers
11 Mar 2025 //
BUSINESSWIRE
XOMA Royalty Q3 2024 Results & Recent Activities
07 Nov 2024 //
GLOBENEWSWIRE
Twist Bioscience To Report Q4 2024 Results On Nov 18
24 Oct 2024 //
BUSINESSWIRE
Twist Bioscience Enters Royalty Purchase Agreement For $15M
22 Oct 2024 //
BUSINESSWIRE
Twist Bioscience Appoints Mike Fero, Ph.D as CIO
15 Oct 2024 //
BUSINESSWIRE
Twist Bioscience Issues 2024 Corporate Responsibility Report
09 Sep 2024 //
BUSINESSWIRE
Twist Bioscience And bitBiome Collaborate On Biocatalysis Enzymes
05 Aug 2024 //
BUSINESSWIRE
Twist Bioscience Launches CHO Express Antibodies For IgG Portfolio
10 Jul 2024 //
BUSINESSWIRE
ONT, Twist Bio Launch Pharmacogenomics Program
22 May 2024 //
BUSINESSWIRE
Twist Bio Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
06 Feb 2024 //
BUSINESSWIRE
Twist Bioscience Enters into Agreement with Ono to Discover Novel Antibodies
31 Aug 2023 //
BUSINESSWIRE
Twist Bioscience Appoints Chet Gandhi as CI Officer
20 Jun 2023 //
BUSINESSWIRE
Twist trims workforce by 25% amid record-high revenues
08 May 2023 //
FIERCE BIOTECH
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
05 May 2023 //
BUSINESSWIRE
Twist Bioscience Enters into Third Collaboration with Astellas
20 Apr 2023 //
BUSINESSWIRE
Twist Begins Shipping Product from Synthetic DNA Manufacturing Factory
26 Jan 2023 //
BUSINESSWIRE
Astellas` intergalactic quest finds 2 pacts with Twist, Selecta
09 Jan 2023 //
FIERCE BIOTECH
